Is Recommending 0.01% Atropine for Myopia Control Clinically Meaningful?

被引：2
|
作者：
Khanal, Safal [1 ]
Phillips, John R. [2 ,3 ]
机构：
[1] Univ Alabama Birmingham, Dept Optometry & Vis Sci, Birmingham, AL USA
[2] Univ Auckland, Sch Optometry & Vis Sci, Auckland, New Zealand
[3] Univ Auckland, Sch Optometry & Vis Sci, 85 Pk Rd, Auckland 1023, New Zealand
来源：
JAMA OPHTHALMOLOGY | 2024年 / 142卷 / 03期
关键词：
D O I：
10.1001/jamaophthalmol.2023.6771
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Is Recommending 0.01% Atropine for Myopia Control Clinically Meaningful?-Reply
    Zadnik, Karla
    Flitcroft, Ian
    Hemmati, Houman D.
    JAMA OPHTHALMOLOGY, 2024, 142 (03) : 272 - 272
  • [2] Atropine, 0.01%, for Myopia Control
    Walline, Jeffrey J. J.
    Berntsen, David A. A.
    JAMA OPHTHALMOLOGY, 2023, 141 (08) : 766 - 767
  • [3] Does 0.01% atropine have a place as a myopia control therapy?
    Phillips, John R.
    Yam, Jason C.
    Khanal, Safal
    OPHTHALMIC AND PHYSIOLOGICAL OPTICS, 2025,
  • [4] Effect of atropine 0.01% on progression of myopia
    Sen, Snigdha
    Yadav, Himanshu
    Jain, Anu
    Verma, Sadhna
    Gupta, Preeti
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2022, 70 (09) : 3373 - 3376
  • [5] Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2 Myopia Control with Atropine 0.01% Eyedrops
    Chia, Audrey
    Lu, Qing-Shu
    Tan, Donald
    OPHTHALMOLOGY, 2016, 123 (02) : 391 - 399
  • [6] Analysis of Factors That May Affect the Effect of Atropine 0.01% on Myopia Control
    Zhang, Xiaoyu
    Wang, Yuliang
    Zhou, Xingtao
    Qu, Xiaomei
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [7] Change in pupil size with atropine 0.01% is not associated with myopia control efficacy
    Dadzie, Emmanuella Esi
    Kobia-Acquah, Emmanuel
    Flitcroft, Ian
    Biba, Matilda
    Loughman, James
    Lingham, Gareth
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [8] NVK002 low-dose atropine 0.01% produced clinically meaningful myopia control over 3 years in the CHAMP phase 3 clinical trial for treatment of pediatric myopia progression
    Hemmati, Houman David
    Fong, Tung
    Chandler, Simon
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [9] Pan-Indian multicentre retrospective study of 0.01% atropine for myopia control
    Yam, Jason C.
    Zhang, Yuzhou
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2024, 108 (04) : 493 - 494
  • [10] Efficacy and Safety of Consecutive Use of 1% and 0.01% Atropine for Myopia Control in Chinese Children: The Atropine for Children and Adolescent Myopia Progression Study
    Luyao Ye
    Hannan Xu
    Ya Shi
    Yao Yin
    Tao Yu
    Yajun Peng
    Shanshan Li
    Jiangnan He
    Jianfeng Zhu
    Xun Xu
    Ophthalmology and Therapy, 2022, 11 : 2197 - 2210
12345